GlassScriptPhysician profile
Jason D Adams
NPI 1942205174
$1,005.85
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $156 · 2021: $230 · 2022: $116 · 2023: $217 · 2024: $67.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $422.73 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $108.55 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $91.75 | 2020-2024 | Gardasil 9, Capvaxive, Gardasil |
| Virtus Pharmaceuticals LLC | $56.61 | 2021 | |
| Millicent US INC | $53.69 | 2019-2024 | Femring, Intrarosa |
| Azurity Pharmaceuticals, INC. | $44.00 | 2023 | Adthyza |
| Hologic Sales and Service, LLC | $35.33 | 2019-2023 | Affirm Prone Biopsy System |
| Astellas Pharma US INC | $31.12 | 2023-2024 | Veozah |
| Avion Pharmaceuticals | $30.55 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $18.67 | 2024 | Myfembree |
| Ibsa Pharma INC. | $17.24 | 2023 | Tirosint, Licart |
| Becton, Dickinson and Company | $17.04 | 2022 | |
| Merz North America, INC. | $15.23 | 2019 | |
| Allergan, INC. | $14.47 | 2019 | |
| Kvk-Tech, INC. | $13.99 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $12.53 | 2020 | |
| Agile Therapeutics, INC. | $11.52 | 2021 | |
| Currax Pharmaceuticals LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.